Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00149136Phase 2Unknown
A Phase 2 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Hospices Civils de Lyon. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00149136.